5 NYSE Healthcare Stocks With The Highest ROE

Below are the top NYSE stocks in the healthcare sector in terms of return on equity. The trailing-twelve-month return on equity at GlaxoSmithKline plc (ADR) GSK is 178.10 percent. GlaxoSmithKline's revenue for the same period is $36.55 billion. The trailing-twelve-month return on equity at Genesis Healthcare Inc GEN is 117.60 percent. Genesis Healthcare's revenue for the same period is $1.97 billion. The trailing-twelve-month return on equity at Novo Nordisk A/S (ADR) NVO is 81.30 percent. Novo Nordisk's revenue for the same period is $14.25 billion. The trailing-twelve-month return on equity at AbbVie Inc ABBV is 56.00 percent. AbbVie's revenue for the same period is $20.44 billion. The trailing-twelve-month return on equity at HealthSouth Corp HLS is 55.50 percent. HealthSouth's revenue for the same period is $2.52 billion.